Francis R.W. Godwin

Francis R.W. Godwin, MBA, is office director, OMQ, OC, and CDER, at FDA.

Articles by Francis R.W. Godwin

CDER, CBER Officials Outline GMP Compliance Trends

ByNicholas Jacobus,Francis R.W. Godwin,Kathleen Jones

September 16th 2026

FDA's Francis R.W. Godwin (CDER) and Kathleen Jones, PhD (CBER) detail a record pace of drug warning letters and the CGMP deficiencies most commonly cited in biologics facility inspections.

Francis R.W. Godwin

Articles by Francis R.W. Godwin

CDER, CBER Officials Outline GMP Compliance Trends

Latest Updated Articles